Pharvaris NV Sustainability Reports
Pharvaris N.V. is a clinical-stage biopharmaceutical company focused on the development and commercialization of oral therapies for rare diseases. It specializes in small-molecule bradykinin B2 receptor antagonists for treating hereditary angioedema.
Sector: Manufacturing
Country: Netherlands
Exchange: Nasdaq
LEI: 9845003BE146D3B75D32
FIGI: BBG00YYCW2H3
1 reports from 2020 to 2020
